EP Patent

EP1945188A2 — Levodopa compositions

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2008-07-23 · 18y expired

What this patent protects

The invention provides compositions of levodopa resulting in extended absorption profiles and methods of treatment using the compositions.

USPTO Abstract

The invention provides compositions of levodopa resulting in extended absorption profiles and methods of treatment using the compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1945188A2
Jurisdiction
EP
Classification
—
Expires
2008-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.